Gregory Gottschlich

Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

Tim Harrison, Pascal Chanez, Francesco Menzella et al. · The Lancet Respiratory Medicine · 2020 · 168 citations · Full text

Asthma, Severe Eosinophilic Asthma, Allergy +10

Efficacy and Safety of Glycopyrrolate/Formoterol Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Patients With COPD

Fernando J. Martínez, Klaus F. Rabe, Gary T. Ferguson et al. · CHEST Journal · 2016 · 102 citations

Pulmonary Care, Advanced Lung Disease, Pulmonary Medicine +3

Oral immunotherapy with short ragweed extract in a novel encapsulated preparation: A double-blind study☆☆☆★★★

Allen Litwin, Michael Flanagan, Gregory Entis et al. · Journal of Allergy and Clinical Immunology · 1997 · 71 citations

Double-blind Study☆☆☆★★★, Medicine, Immunoengineering +7

Immunologic Effects of Encapsulated Short Ragweed Extract: a Potent New Agent for Oral Immunotherapy

Allen Litwin, Michael Flanagan, Gregory Entis et al. · Annals of Allergy Asthma & Immunology · 1996 · 33 citations

Immunotoxicology, Medicine, Immunology +9

A multicenter, randomized, double-blind dose-ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared to the monocomponents and open-label tiotropium dry powder inhaler in patients with moderate-to-severe COPD

Donald P. Tashkin, Fernando J. Martínez, Roberto Rodríguez-Roisin et al. · Respiratory Medicine · 2016 · 21 citations · Full text